ArticleNature communications2022

Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.

Vincent Pavot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.